News and Announcements
Innovative Cancer Solutions: Cartherics’s Patented Immunotherapy Approach
- Published October 01, 2024 12:26AM UTC
- Publisher Maan Perez
- Categories Executive Interviews
Ian Nisbet, COO of Cartherics, shares insights into their innovative immunotherapy solutions for cancer. Discover how their stem cell platform, recent European patent, and collaborations are driving advancements in cancer treatment. Stay informed about the latest in cell-based cancer therapies.
Executive Interviews
Why Are Fewer Companies Going Public?
The number of companies listing on the ASX has declined, driven by access to private capital, regulatory burdens, and market volatility. However, public markets still offer liquidity, visibility, and robust capital-raising opportunities.
A Message to Founders: A Shared Journey to 2025 – A Once in a Generation Opportunity
As we close this challenging year, let’s reflect on the resilience, lessons, and growth that brought us here. Founders, 2025 is your golden opportunity to innovate, scale, and thrive. Set your strategy, rest, and prepare to sprint into a year of unparalleled possibilities.
From Trash to Treasure: Inside Australia’s First Commercial Waste-to-Hydrogen Facility
Greenhill Energy’s pioneering waste-to-hydrogen facility marks a significant step in sustainable energy. This Australian innovation is transforming waste management into clean, valuable hydrogen, presenting investors with a unique, forward-thinking opportunity.
Backed By Leading Investment Groups and Family Offices
